CLINICAL_TRIALS
trial_result
· 2011-07-26
Clinical Trial Update: Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP) [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of asfotase alfa in juvenile patients with hypophosphatasia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia (HPP) | Phase 2 | Status: COMPLETED | Results posted: 2011-07-26